InvestSMART

Pro Medicus Limited (ASX: PME) - Announcements

Current share price for PME : $173.600 6.44 (3.58%)+

ASX company news and announcements for Pro Medicus Limited (PME) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pro Medicus Limited (PME) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pro Medicus Limited (PME), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pro Medicus Limited (PME)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18,136 Change of Director's Interest Notice - Deena Shiff 16 Feb 2026 8:19AM $118.220 $173.600 risen by 46.84%
$18,136 HY26 Results Presentation 12 Feb 2026 9:49AM $169.470 $173.600 risen by 2.44%
$18,136 Dividend/Distribution - PME 12 Feb 2026 9:34AM $169.470 $173.600 risen by 2.44%
$18,136 CEO Interview - 1HY26 12 Feb 2026 9:21AM $169.470 $173.600 risen by 2.44%
$18,136 Company Announcement - Interim Results 12 Feb 2026 9:19AM $169.470 $173.600 risen by 2.44%
$18,136 Half Year Accounts 12 Feb 2026 9:09AM $169.470 $173.600 risen by 2.44%
$18,136 Appendix 4D 12 Feb 2026 9:09AM $169.470 $173.600 risen by 2.44%
$18,136 PME HY Results release date and webcast briefing 19 Jan 2026 12:05PM $194.170 $173.600 fallen by 10.59%
$18,136 Notification regarding unquoted securities - PME 13 Jan 2026 6:57PM $209.660 $173.600 fallen by 17.20%
$18,136 Notification of cessation of securities - PME 13 Jan 2026 11:23AM $212.155 $173.600 fallen by 18.17%
$18,136 Notification regarding unquoted securities - PME 13 Jan 2026 11:18AM $212.030 $173.600 fallen by 18.12%
$18,136 Notification regarding unquoted securities - PME 13 Jan 2026 11:10AM $212.030 $173.600 fallen by 18.12%
$18,136 Notification of cessation of securities - PME 5 Jan 2026 5:31PM $215.300 $173.600 fallen by 19.37%
$18,136 Change of Director's Interest Notice - Peter Kempen 30 Dec 2025 11:34AM $224.010 $173.600 fallen by 22.50%
$18,136 Change of Director's Interest Notice - Anthony Hall 23 Dec 2025 8:24AM $222.300 $173.600 fallen by 21.91%
$18,136 Change of Director's Interest Notice - Sam Hupert 23 Dec 2025 8:24AM $222.300 $173.600 fallen by 21.91%
$18,136 Change of Director's Interest Notice - Anthony Hall 22 Dec 2025 8:59AM $217.370 $173.600 fallen by 20.14%
$18,136 Change of Director's Interest Notice - Sam Hupert 22 Dec 2025 8:57AM $217.370 $173.600 fallen by 20.14%
$18,136 Update - Notification of buy-back - PME 19 Dec 2025 8:32AM $214.860 $173.600 fallen by 19.20%
$18,136 Update - Notification of buy-back - PME 16 Dec 2025 8:45AM $233.690 $173.600 fallen by 25.71%
$18,136 Update - Notification of buy-back - PME 15 Dec 2025 9:48AM $234.430 $173.600 fallen by 25.95%
$18,136 Update - Notification of buy-back - PME 12 Dec 2025 8:55AM $232.990 $173.600 fallen by 25.49%
$18,136 Update - Notification of buy-back - PME 11 Dec 2025 8:55AM $237.490 $173.600 fallen by 26.90%
$18,136 Update - Notification of buy-back - PME 9 Dec 2025 8:36AM $246.670 $173.600 fallen by 29.62%
$18,136 PME Response to speculation 4 Dec 2025 9:57AM $254.330 $173.600 fallen by 31.74%

26 - 50 of 668 results

Page 2 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.